• Tue, May 24, 2022
Andrea Tan Maintained (VOR) at Hold with Decreased Target to $4 on, May 24th, 2022
Andrea Tan of Goldman Sachs, Maintained "Vor Biopharma Inc." (VOR) at Hold with Decreased Target from $6 to $4 on, May 24th, 2022.
Andrea has made no other calls on VOR in the last 4 months.
There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Andrea's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrea
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $15 on, Friday, May 13th, 2022
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $26 on, Monday, March 21st, 2022